Risedronate Sodium Hydrate
Tier C — Watch / tradeRisedronate Sodium Hydrate
Targets：FDPS
Brand：Actonel, Acrel, Benet, Atelvia, Optinate
Indications (approved)：Paget's disease, Postmenopausal osteoporosis, Osteoporosis, Glucocorticoid-induced osteoporosis
Regional status
Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| RISE-001 | 501-81-5 | 2-(pyridin-3-yl)acetic acid |
| RISE-002 | 2087975-91-3 | sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate |
| Code | CAS No. | Intermediate |
|---|---|---|
| RISE-003 | 6419-36-9 | 2-(pyridin-3-yl)acetic acid hydrochloride |
Frequently asked questions
What are the approved indications of Risedronate Sodium Hydrate?
Approved indications include: Paget's disease, Postmenopausal osteoporosis, Osteoporosis, Glucocorticoid-induced osteoporosis.
When does the Risedronate Sodium Hydrate patent expire?
No public expiry year is available for Risedronate Sodium Hydrate yet; this page updates once verified.
How many synthesis routes are recorded for Risedronate Sodium Hydrate?
2 synthesis routes are recorded; the shortest is 2 steps with 16 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Risedronate Sodium Hydrate intermediates?
All intermediates in Risedronate Sodium Hydrate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Risedronate Sodium Hydrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29